Literature DB >> 21320863

B-type natriuretic peptide: diagnostic and therapeutic applications in infants and children.

Joseph D Tobias1.   

Abstract

The natriuretic peptide system plays an active role in the regulation of fluid balance and systemic vascular resistance. Peptides of the natriuretic system produced through recombinant DNA technology are now available for clinical use including both atrial natriuretic peptide (ANP) and brain-type natriuretic peptide (BNP). Assays of BNP are available and may be used for both diagnostic and prognostic purposes in various clinical scenarios. The basic physiology of the natriuretic peptide system is presented, applications of BNP monitoring as a diagnostic tool are reviewed, and reports regarding the use of recombinant BNP in the pediatric population are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21320863     DOI: 10.1177/0885066610387993

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  4 in total

1.  What Is High Enough? Elevated NT-pro-BNP in Decompensated Paroxysmal Supraventricular Tachycardia.

Authors:  Shawn Reeves; Clayton Womack; L O Lutherer; Christopher Todd; Kerrie Pinkney; Thivakorn Kasemsri
Journal:  J Pediatr Intensive Care       Date:  2017-06-12

2.  Tissue Doppler septal Tei index indicates severity of illness in pediatric patients with congestive heart failure.

Authors:  Aura A Sanchez Mejia; Kathleen E Simpson; Charles F Hildebolt; Elfriede Pahl; Kathleen L Matthews; Cheryl A Rainey; Charles E Canter; Patrick Y Jay; Mark C Johnson
Journal:  Pediatr Cardiol       Date:  2013-09-24       Impact factor: 1.655

3.  Cardiac Dysfunction in a Porcine Model of Pediatric Malnutrition.

Authors:  Christian Fabiansen; Mikkel Lykke; Anne-Louise Hother; Jørgen Koch; Ole Bækgaard Nielsen; Ingrid Hunter; Jens P Goetze; Henrik Friis; Thomas Thymann
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

4.  Short-Term Evaluation of Left Ventricular Mass and Function in Children With Growth Hormone Deficiency After Replacement Treatment.

Authors:  E Gómez-Guzmán; M D Cañete; R Valle-Martos; R Cañete; M Valle; L Jiménez-Reina; J Caballero-Villarraso
Journal:  Front Pediatr       Date:  2018-06-19       Impact factor: 3.418

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.